Roberto Hernán

1.3k total citations
10 papers, 957 citations indexed

About

Roberto Hernán is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Roberto Hernán has authored 10 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in Roberto Hernán's work include Glioma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Roberto Hernán is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Neuroblastoma Research and Treatments (4 papers) and Protein Degradation and Inhibitors (4 papers). Roberto Hernán collaborates with scholars based in United States, United Kingdom and Australia. Roberto Hernán's co-authors include Richard J. Gilbertson, Adrian Frank, Youngsoo Lee, Peter J. McKinnon, David W. Ellison, Amar Gajjar, Tom Curran, Michele Connelly, Cynthia Wetmore and Christine Fuller and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and European Journal of Cancer.

In The Last Decade

Roberto Hernán

10 papers receiving 939 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Hernán United States	9	693	518	214	212	150	10	957
Martyna Adamowicz‐Brice United Kingdom	6	485 0.7×	446 0.9×	137 0.6×	209 1.0×	188 1.3×	7	826
Meryl E. Lusher United Kingdom	12	898 1.3×	651 1.3×	125 0.6×	145 0.7×	231 1.5×	14	1.1k
David Shih United States	16	668 1.0×	533 1.0×	155 0.7×	129 0.6×	230 1.5×	35	1.1k
Francisco J. Cordero United States	7	936 1.4×	619 1.2×	152 0.7×	233 1.1×	218 1.5×	9	1.3k
Monica Hermanson Sweden	12	635 0.9×	447 0.9×	307 1.4×	105 0.5×	228 1.5×	15	1.2k
A. Guha United States	15	383 0.6×	359 0.7×	179 0.8×	333 1.6×	169 1.1×	23	1.1k
Shoji Shiraishi Japan	10	396 0.6×	601 1.2×	235 1.1×	115 0.5×	260 1.7×	10	947
Carl Koschmann United States	18	428 0.6×	530 1.0×	181 0.8×	188 0.9×	249 1.7×	79	935
Julian Board United Kingdom	7	494 0.7×	404 0.8×	284 1.3×	322 1.5×	258 1.7×	7	961
Amanda Saratsis United States	16	710 1.0×	629 1.2×	187 0.9×	219 1.0×	301 2.0×	35	1.2k

Countries citing papers authored by Roberto Hernán

Since Specialization

Citations

This map shows the geographic impact of Roberto Hernán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Hernán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Hernán more than expected).

Fields of papers citing papers by Roberto Hernán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Hernán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Hernán. The network helps show where Roberto Hernán may publish in the future.

Co-authorship network of co-authors of Roberto Hernán

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Hernán. A scholar is included among the top collaborators of Roberto Hernán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Hernán. Roberto Hernán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Rosell‐Valle, Cristina, C. Antúnez, Fernando Campos, et al.. (2021). Evaluation of the effectiveness of a new cryopreservation system based on a two-compartment vial for the cryopreservation of cell therapy products. Cytotherapy. 23(8). 740–753. 3 indexed citations

Gilbertson, Richard J., Roberto Hernán, Twala L. Hogg, et al.. (2006). Mutational analysis of PDGFR–RAS/MAPK pathway activation in childhood medulloblastoma. European Journal of Cancer. 42(5). 646–649. 30 indexed citations

Frank, Adrian, Roberto Hernán, Janet C. Lindsey, et al.. (2004). The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma. Molecular Brain Research. 121(1-2). 137–140. 47 indexed citations

Gajjar, Amar, Roberto Hernán, Mehmet Koçak, et al.. (2004). Clinical, Histopathologic, and Molecular Markers of Prognosis: Toward a New Disease Risk Stratification System for Medulloblastoma. Journal of Clinical Oncology. 22(6). 984–993. 192 indexed citations

Hernán, Roberto, Christopher Calabrese, Adrian Frank, et al.. (2003). ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma.. PubMed. 63(1). 140–8. 140 indexed citations

Lee, Youngsoo, Heather Lee Miller, Patricia Jensen, et al.. (2003). A molecular fingerprint for medulloblastoma.. PubMed. 63(17). 5428–37. 156 indexed citations

Gilbertson, Richard J., D. Ashley Hill, Roberto Hernán, et al.. (2003). ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma.. PubMed. 9(10 Pt 1). 3620–4. 92 indexed citations

Gilbertson, Richard J., Roberto Hernán, Teemu T. Junttila, et al.. (2002). ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.. PubMed. 8(10). 3054–64. 127 indexed citations

Gilbertson, Richard J., Roberto Hernán, Torsten Pietsch, et al.. (2001). Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma. Genes Chromosomes and Cancer. 31(3). 288–294. 43 indexed citations

10.

Gilbertson, Richard J., Roberto Hernán, Balaji Veeraraghavan, et al.. (2001). Clinical and molecular stratification of disease risk in medulloblastoma. British Journal of Cancer. 85(5). 705–712. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact